Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

NCT01215357 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Pathological Gambling

Interventions

DRUG: Ecopipam

Sponsor

Emalex Biosciences Inc.

Collaborators

[object Object]